Condition (MeSH)
Intracranial Embolism and Thrombosis
ClinicalTrials.gov lists 80 trials for Intracranial Embolism and Thrombosis or a narrower condition beneath it.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials per phase
8 of the 80 trials are tagged with Intracranial Embolism and Thrombosis itself; the rest are tagged with a narrower condition beneath it.
When did Intracranial Embolism and Thrombosis trials start? (24)
Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Trials over time, by phase
- Phase 1/2
- Phase 2
- Phase 2/3
- Phase 3
- Phase 4
- Not applicable
- Observational
Top of scale: 11
Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.
| Year | Trials started |
|---|---|
| 2026 (partial year) | 3 |
| 2025 | 4 |
| 2024 | 1 |
| 2023 | 2 |
| 2022 | 5 |
| 2021 | 5 |
| 2020 | 3 |
| 2019 | 7 |
| 2018 | 4 |
| 2017 | 11 |
Showing 10 of 24 earlier years.
No forecast is made for this condition: it averages 3.0 trial starts a year over the five years to September, under the 5 a year the method needs.
Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
What phase are Intracranial Embolism and Thrombosis trials in? (7)
Shown in this order: phase order.
Show the trials by phase as a table
| Phase | Trials |
|---|---|
| Phase 1/2 | 2 |
| Phase 2 | 2 |
| Phase 2/3 | 2 |
| Phase 3 | 13 |
| Phase 4 | 3 |
| Not applicable | 19 |
| Observational | 39 |
How many Intracranial Embolism and Thrombosis trials are recruiting? (6)
Shown in this order: the order a trial moves through, from not yet recruiting to unknown.
| Status | Trials |
|---|---|
| Recruiting | 15 |
| Active, not recruiting | 5 |
| Completed | 43 |
| Suspended | 1 |
| Terminated | 4 |
Showing 5 of 6 statuses.
Status as registered on ClinicalTrials.gov. Each trial is counted once.
Which lead sponsors run the most Intracranial Embolism and Thrombosis trials? (4)
Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.
| Sponsor | Trials |
|---|---|
| Acandis GmbH | 1 |
| AorticLab Srl | 1 |
| Archemix Corp. | 1 |
| Auckland City Hospital | 1 |
Which drugs are being tested for Intracranial Embolism and Thrombosis? (2)
Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.
| Drug | Trials |
|---|---|
| Rivaroxaban | 7 |
| Tenecteplase | 2 |
Interventions as named in the registry (13)
Shown in this order: most trials first.
| Drug | Trials |
|---|---|
| Warfarin VKA | 5 |
| Apixaban IR | 4 |
| BIBR 1048 low1 | 3 |
| Alteplase t-PA | 2 |
| BLOOD SAMPLES | 1 |
Showing 5 of 13 interventions.
These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.
Which serious adverse events do Intracranial Embolism and Thrombosis trials report? (10)
Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.
| Adverse event | Subjects affected | Trials |
|---|---|---|
| Neoplasms benign, malignant and unspecified (incl cysts and polyps) - Other, specify | 56 | 1 |
| Neoplasms benign, mal, uncpec - Oth spec | 40 | 1 |
| Sepsis | 21 | 2 |
| Anemia | 15 | 2 |
| Small intestinal obstruction | 15 | 2 |
Showing 5 of 10 adverse events.
Which publications cover Intracranial Embolism and Thrombosis? (62)
Shown in this order: major-topic papers first, then newest, then most linked to trials.
| Publication | Journal | Year | Major topic |
|---|---|---|---|
| Angiogenesis and improved cerebral blood flow in the ischemic boundary area detected by MRI after administration of sildenafil to rats with embolic stroke. | Brain research | 2007 | Yes |
| Frequent atrial premature beats predict paroxysmal atrial fibrillation in stroke patients: an opportunity for a new diagnostic strategy. | Stroke | 2007 | Yes |
| Incidence of new brain lesions after carotid stenting with and without cerebral protection. | Stroke | 2006 | Yes |
| [Headache in patients with cerebral venous thrombosis]. | Revue neurologique | 2005 | Yes |
| Solid and gaseous cerebral microembolization during off-pump, on-pump, and open cardiac surgery procedures. | The Journal of thoracic and cardiovascular surgery | 2004 | Yes |
Showing 5 of 62 publications.
Sub-conditions in MeSH (3)
MeSH descendants one level down with at least one trial, most trials first.
Not on this page
Not measured: delivery record.
Checked, with nothing recorded for this condition: prevalence and rare-disease identity.